![](/img/cover-not-exists.png)
PMO-145 Ethnicity has no impact on SVR rates in patients with HCV genotype 3 treated with pegylated interferon and ribavirin: Abstract PMO-145 Figure 1
Evans, A, Linzey, D, Booth, JVolume:
61
Language:
english
Journal:
Gut
DOI:
10.1136/gutjnl-2012-302514b.145
Date:
July, 2012
File:
PDF, 132 KB
english, 2012